全球免疫比浊法试剂市场，按适应症（肾功能测试、糖尿病、高血压、IVD 测试）、应用（蛋白质组学、药物发现和开发、基因组学）、技术（蛋白质印迹法、免疫荧光法、免疫组织化学法、流式细胞术、酶联免疫吸附试验、多重免疫吸附试验、免疫沉淀法、其他）、最终用户（医院、家庭护理环境、临床实验室、其他）划分——行业趋势和预测到 2029 年。
免疫比浊法试剂市场分析及规模
免疫比浊法 (IT) 是临床化学领域中一项重要的诊断技术。它用于识别使用传统临床化学方法和抗原抗体反应无法检测到的血清蛋白。免疫比浊法依赖于抗原和抗体之间特异性和灵敏性的相互作用。每种抗体都与不同的抗原（钥匙和锁）结合。
Data Bridge Market Research 分析，免疫比浊法试剂市场预计在 2022 年至 2029 年的预测期内实现 6.50% 的健康复合年增长率。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解之外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
免疫比浊法试剂市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
适应症（肾功能测试、糖尿病、高血压、IVD 测试）、应用（蛋白质组学、药物发现和开发、基因组学）、技术（蛋白质印迹法、免疫荧光法、免疫组织化学法、流式细胞术、酶联免疫吸附试验、多重免疫吸附试验、免疫沉淀法、其他）、最终用户（医院、家庭护理机构、临床实验室、其他） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。 |
|
涵盖的市场参与者 |
西门子医疗私人有限公司（德国）、朗道实验室有限公司（英国）、BBI Solutions（英国）、雅培（美国）、富士胶片印度私人有限公司（美国）、Erba Mannheim（德国）和 Biocompare（美国） |
|
市场机会 |
|
Market Definition
Immunoturbidimetry is an appropriate technique for determining urinary proteins in clinical laboratories. We created immunoturbidimetric assays for measuring urinary albumin and transferrin that are compatible with the Cobas-BIO centrifugal analyzer. The ability of immune-complex precipitates to interact with incident light is quantified using turbidimetry (immunoturbidimetry) and nephelometry (immunonephelometry). The detector is oriented at a straight-on 180-degree angle relative to the incident light source for turbidimetric measurements. Immunoturbidimetry Reagents are available for the estimation of RF, ASO, CRP and Direct HbA1c.
Global Immunoturbidimetry Reagents Market Dynamics
Drivers
- Growing need of IVD testing
The growing demand for IVD testing is driven by rising rates of chronic and infectious diseases, as well as an ageing population prone to immunological disorders. Furthermore, increased use of personalised medicines and increased awareness of rare diseases are propelling the market. Another rise in testing specific proteins for infectious diseases, cardiac diseases, diabetes, autoimmune disorders, inflammatory markers, and other conditions has been observed. These are the certain factors which propel the growth of market.
- Rising cardiovascular diseases
India is experiencing a rapid demographic transition. By 2050, the percentage population of the elderly (aged 60 and up) is expected to increase by about 20%. According to the LASI (The Longitudinal Ageing Study in India) report, the burden of noncommunicable illness is increasing. It is estimated that 45 million people have cardiovascular disease and high blood pressure, 20 million have diabetes, and 24% have difficulty performing daily activities and this factor is propelling the growth of the market.
Opportunities
- Rising number of patients
The rising number of patients suffering from breast autoimmune disorders, cardiac diseases, diabetes, infectious diseases, and inflammatory markers is expected to have a significant impact on the immunoturbidimetry reagents market from 2022 to 2029. On the other hand, the growing patient population will create additional opportunities for the immunoturbidimetry reagents market during the forecast period.
Restraints/Challenges
- High consumables cost
High consumables costs and need of trained and experienced personal will hamper the growth of the immunoturbidimetry reagents will obstruct the market's growth rate.
High consumable costs necessitate highly trained person. Immunoturbidimetric tests are performed on routine biochemistry analyzers, which are versatile, fast, and cost-effective, with longer reagent stability. The primary benefit of nephelometry was its sensitivity; however, latex-enhanced immunoturbidimetry has closed this gap.
本免疫比浊法试剂市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关免疫比浊法试剂市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
全球免疫比浊法试剂市场范围
免疫比浊法试剂市场根据适应症、应用、技术和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
指征
- 肾功能检查
- 糖尿病
- 高血压
- 体外诊断试剂
应用
- 蛋白质组学
- 药物研发
- 基因组学
技术
- 蛋白质印迹法
- 免疫荧光
- 免疫组织化学
- 流式细胞术
- 酶联免疫吸附试验
- 多重免疫吸附试验
- 免疫沉淀
- 其他的
最终用户
- 医院
- 家庭护理环境
- 临床实验室
- 其他的
免疫比浊法试剂市场区域分析/见解
对免疫比浊法试剂市场进行了分析，并按国家、适应症、应用、技术和最终用户提供了市场规模见解和趋势。
免疫比浊法试剂市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于本地参与者在市场上占据主导地位，并且靶向免疫疗法的采用率不断上升，北美在免疫比浊法试剂市场中占据主导地位。
由于人们对糖尿病和高血压相关疾病的认识不断提高，预计亚太地区在 2022 年至 2029 年的预测期内将实现最高增长率。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和免疫比浊法试剂市场份额分析
免疫比浊法试剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对免疫比浊法试剂市场的关注有关。
免疫比浊法试剂市场的一些主要参与者包括：
- 西门子医疗私人有限公司（德国）
- Randox Laboratories Ltd.（英国）
- BBI Solutions（英国）
- 雅培（美国）
- 富士胶片印度私人有限公司（美国）
- 埃尔巴·曼海姆（德国）
- Biocompare（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
